This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Siemens Spreads Message Of Hope, Highlights The Promise Of Research Through “The Baton Pass” Campaign Benefiting “Stand Up To Cancer”

Stocks in this article: SI

Siemens, one of the world’s leading engineers of medical imaging, laboratory diagnostics and healthcare IT solutions, is leading a campaign called “The Baton Pass™” that will raise funds for Stand Up To Cancer® (SU2C), a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, to support its innovative cancer research, designed to get new therapies to patients quickly.

“The Baton Pass” links the strong hope for survivorship for everyone facing a cancer diagnosis with the critical need to invest in research. The Baton will be passed at events across the country, touching the hands of patients, survivors, doctors, scientists, health care workers, families and anyone who has been affected by cancer, signifying how we are all united in the fight against this disease. The Baton includes a GPS tracking system that allows users of the Facebook app to follow the Baton’s journey during the course of the campaign. Everyone can participate in the campaign by visiting Facebook.Com/TheBatonPass, which hosts an app where users can virtually “pass” the baton in dedication of loved ones contending with cancer or whose lives were taken by it. The app also provides a simple way for individuals to make donations to Stand Up To Cancer.

Siemens is jump-starting the fundraising effort by donating one dollar to SU2C for every pass of the Baton -- physically and online -- up to $1 million, from March 19 through September 5, 2014.

“Siemens shares Stand Up To Cancer’s core belief that accelerating the pace at which scientific discoveries are translated to clinical settings is a vital component of the effort to save more lives from cancer,” said Gregory Sorensen, MD, CEO, Siemens Healthcare North America. “Medical imaging and laboratory diagnostic technologies help make these scientific discoveries possible and enable doctors to save lives every day. Siemens Healthcare is proud to engage the public in supporting the SU2C Dream Team researchers through this grassroots campaign.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs